Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy
Status:
Unknown status
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The aim of this prospective, randomized, controlled study is to investigate the effect of
pretreatment with intravenous Alprostadil on the incidence of CIN in a high-risk population
of patients with both type 2 diabetes mellitus (T2DM) and CKD undergoing coronary
angiography, and evaluate the influence of such potential benefit on short-term outcome.